can glp 1 cause cancer Glucagon-like peptide-1 receptor agonists and risk of gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials GLP-1 receptor agonists in the

In research published in the journal Diabetes, Obesity and Metabolism on nearly 2,000 adults with obesity, participants took weekly semaglutide injections in addition to making healthy lifestyle changes for 68 weeks, then stopped

For patients with established Crohn's disease who are considering or currently taking GLP-1 receptor agonists, careful clinical assessment and ongoing monitoring are essential

Lancet 1989;2:469-73

People with uncontrolled diabetes, active cancer, or certain other health conditions may not be appropriate candidates

The prohibitive cost of prescription drugs is a pervasive and pressing issue, especially for underserved populations such as women and BIPOC communities

You should avoid alcohol or have to follow doctor advice related to diet while taking this medicine